Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

July 01, 2012; Volume 40,Issue 7

Minireview

  • You have access
    Unusual Glucuronides
    Upendra A. Argikar
    Drug Metabolism and Disposition July 2012, 40 (7) 1239-1251; DOI: https://doi.org/10.1124/dmd.112.045096

Short Communications

  • You have access
    Effect of Glucagon-Like Peptide 2 on Hepatic, Renal, and Intestinal Disposition of 1-Chloro-2,4-dinitrobenzene
    Silvina S. M. Villanueva, Virginia G. Perdomo, María L. Ruiz, Juan P. Rigalli, Agostina Arias, Marcelo G. Luquita, Mary Vore, Viviana A. Catania and Aldo D. Mottino
    Drug Metabolism and Disposition July 2012, 40 (7) 1252-1258; DOI: https://doi.org/10.1124/dmd.111.044339
  • You have access
    Reevaluation of a Quantitative Structure Pharmacokinetic Model for Biliary Excretion in Rats
    Yash A. Gandhi and Marilyn E. Morris
    Drug Metabolism and Disposition July 2012, 40 (7) 1259-1262; DOI: https://doi.org/10.1124/dmd.112.044842
  • You have access
    In Vitro Hepatotoxicity and Cytochrome P450 Induction and Inhibition Characteristics of Carnosic Acid, a Dietary Supplement with Antiadipogenic Properties
    Leslie J. Dickmann, Brooke M. VandenBrink and Yvonne S. Lin
    Drug Metabolism and Disposition July 2012, 40 (7) 1263-1267; DOI: https://doi.org/10.1124/dmd.112.044909

Articles

  • You have access
    In Vitro Evaluation of the Interaction Potential of Irosustat with Drug-Metabolizing Enzymes
    Verònica Ventura, Josep Solà, Concepción Peraire, Françoise Brée and Rosendo Obach
    Drug Metabolism and Disposition July 2012, 40 (7) 1268-1278; DOI: https://doi.org/10.1124/dmd.111.044271
  • You have access
    A Comprehensive Assessment of Repaglinide Metabolic Pathways: Impact of Choice of In Vitro System and Relative Enzyme Contribution to In Vitro Clearance
    Carolina Säll, J. Brian Houston and Aleksandra Galetin
    Drug Metabolism and Disposition July 2012, 40 (7) 1279-1289; DOI: https://doi.org/10.1124/dmd.112.045286
  • You have access
    A Simple Liquid Chromatography-Tandem Mass Spectrometry Method to Determine Relative Plasma Exposures of Drug Metabolites across Species for Metabolite Safety Assessments (Metabolites in Safety Testing). II. Application to Unstable Metabolites
    Hongying Gao and R. Scott Obach
    Drug Metabolism and Disposition July 2012, 40 (7) 1290-1296; DOI: https://doi.org/10.1124/dmd.112.044552
  • You have access
    Metabolite Profiling of Bendamustine in Urine of Cancer Patients after Administration of [14C]Bendamustine
    Anne-Charlotte Dubbelman, Robert S. Jansen, Hilde Rosing, Mona Darwish, Edward Hellriegel, Philmore Robertson, Jan H. M. Schellens and Jos H. Beijnen
    Drug Metabolism and Disposition July 2012, 40 (7) 1297-1307; DOI: https://doi.org/10.1124/dmd.112.045229
  • You have access
    Assessment of Exposure of Metabolites in Preclinical Species and Humans at Steady State from the Single-Dose Radiolabeled Absorption, Distribution, Metabolism, and Excretion Studies: A Case Study
    Chandra Prakash, Zhaoyang Li, Cesare Orlandi and Lewis Klunk
    Drug Metabolism and Disposition July 2012, 40 (7) 1308-1320; DOI: https://doi.org/10.1124/dmd.112.044933
  • You have access
    Neonatal Development of Hepatic UGT1A9: Implications of Pediatric Pharmacokinetics
    Shogo J. Miyagi, Alison M. Milne, Michael W. H. Coughtrie and Abby C. Collier
    Drug Metabolism and Disposition July 2012, 40 (7) 1321-1327; DOI: https://doi.org/10.1124/dmd.111.043752
  • You have access
    Species-Dependent Uptake of Glycylsarcosine but Not Oseltamivir in Pichia pastoris Expressing the Rat, Mouse, and Human Intestinal Peptide Transporter PEPT1
    Yongjun Hu, Xiaomei Chen and David E. Smith
    Drug Metabolism and Disposition July 2012, 40 (7) 1328-1335; DOI: https://doi.org/10.1124/dmd.111.044263
  • You have access
    Time-Dependent Inhibition and Estimation of CYP3A Clinical Pharmacokinetic Drug-Drug Interactions Using Plated Human Cell Systems
    Daniel R. Albaugh, Cody L. Fullenwider, Michael B. Fisher and J. Matthew Hutzler
    Drug Metabolism and Disposition July 2012, 40 (7) 1336-1344; DOI: https://doi.org/10.1124/dmd.112.044644
  • You have access
    Characterization of the In Vitro and In Vivo Metabolism and Disposition and Cytochrome P450 Inhibition/Induction Profile of Saxagliptin in Human
    Hong Su, David W. Boulton, Anthony Barros, Lifei Wang, Kai Cao, Samuel J. Bonacorsi, Ramaswamy A. Iyer, W. Griffith Humphreys and Lisa J. Christopher
    Drug Metabolism and Disposition July 2012, 40 (7) 1345-1356; DOI: https://doi.org/10.1124/dmd.112.045450
  • You have access
    Identification of the Cytochrome P450 and Other Enzymes Involved in the In Vitro Oxidative Metabolism of a Novel Antidepressant, Lu AA21004
    Mette G. Hvenegaard, Benny Bang-Andersen, Henrik Pedersen, Morten Jørgensen, Ask Püschl and Lars Dalgaard
    Drug Metabolism and Disposition July 2012, 40 (7) 1357-1365; DOI: https://doi.org/10.1124/dmd.112.044610
  • You have access
    Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice
    Lauren M. Aleksunes and Curtis D. Klaassen
    Drug Metabolism and Disposition July 2012, 40 (7) 1366-1379; DOI: https://doi.org/10.1124/dmd.112.045112
  • You have access
    Nano-Advantage in Enhanced Drug Delivery with Biodegradable Nanoparticles: Contribution of Reduced Clearance
    Rajendra S. Kadam, David W. A. Bourne and Uday B. Kompella
    Drug Metabolism and Disposition July 2012, 40 (7) 1380-1388; DOI: https://doi.org/10.1124/dmd.112.044925
  • You have access
    Simultaneous Absolute Protein Quantification of Carboxylesterases 1 and 2 in Human Liver Tissue Fractions using Liquid Chromatography-Tandem Mass Spectrometry
    Yuichiro Sato, Aiji Miyashita, Takafumi Iwatsubo and Takashi Usui
    Drug Metabolism and Disposition July 2012, 40 (7) 1389-1396; DOI: https://doi.org/10.1124/dmd.112.045054
  • You have access
    Probabilistic Orthology Analysis of the ATP-Binding Cassette Transporters: Implications for the Development of Multiple Drug Resistance Phenotype
    Ciaran Fisher, Tanya Coleman and Nick Plant
    Drug Metabolism and Disposition July 2012, 40 (7) 1397-1402; DOI: https://doi.org/10.1124/dmd.112.045062
  • You have access
    Effect of Multiple Cysteine Substitutions on the Functionality of Human Multidrug Resistance Protein 1 Expressed in Human Embryonic Kidney 293 Cells: Identification of Residues Essential for Function
    Lei Qin, Shui-Pang Tam and Roger G. Deeley
    Drug Metabolism and Disposition July 2012, 40 (7) 1403-1413; DOI: https://doi.org/10.1124/dmd.112.044867
  • You have access
    Interaction of Lapatinib with Cytochrome P450 3A5
    Eric Chun Yong Chan, Lee Sun New, Teck Beng Chua, Chun Wei Yap, Han Kiat Ho and Sidney D. Nelson
    Drug Metabolism and Disposition July 2012, 40 (7) 1414-1422; DOI: https://doi.org/10.1124/dmd.112.044958
  • You have access
    Interaction between Two Sulfate-Conjugated Uremic Toxins, p-Cresyl Sulfate and Indoxyl Sulfate, during Binding with Human Serum Albumin
    Hiroshi Watanabe, Tsuyoshi Noguchi, Yohei Miyamoto, Daisuke Kadowaki, Shunsuke Kotani, Makoto Nakajima, Shigeyuki Miyamura, Yu Ishima, Masaki Otagiri and Toru Maruyama
    Drug Metabolism and Disposition July 2012, 40 (7) 1423-1428; DOI: https://doi.org/10.1124/dmd.112.045617
  • You have access
    Sequential Metabolism of AMG 487, a Novel CXCR3 Antagonist, Results in Formation of Quinone Reactive Metabolites That Covalently Modify CYP3A4 Cys239 and Cause Time-Dependent Inhibition of the Enzyme
    Kirk R. Henne, Thuy B. Tran, Brooke M. VandenBrink, Dan A. Rock, Divesh K. Aidasani, Raju Subramanian, Andrew K. Mason, David M. Stresser, Yohannes Teffera, Simon G. Wong, Michael G. Johnson, Xiaoqi Chen, George R. Tonn and Bradley K. Wong
    Drug Metabolism and Disposition July 2012, 40 (7) 1429-1440; DOI: https://doi.org/10.1124/dmd.112.045708
  • You have access
    Hydralazine As a Selective Probe Inactivator of Aldehyde Oxidase in Human Hepatocytes: Estimation of the Contribution of Aldehyde Oxidase to Metabolic Clearance
    Timothy J. Strelevitz, Christine C. Orozco and R. Scott Obach
    Drug Metabolism and Disposition July 2012, 40 (7) 1441-1448; DOI: https://doi.org/10.1124/dmd.112.045195

Errata

  • You have access
    Correction to “A Semiphysiological Population Model for Prediction of the Pharmacokinetics of Drugs under Liver and Renal Disease Conditions”
    Drug Metabolism and Disposition July 2012, 40 (7) 1449; DOI: https://doi.org/10.1124/dmd.40.7.1449
  • You have access
    Correction to “Pharmacokinetic Analysis of Continuous Erythropoietin Receptor Activator Disposition in Adult Sheep Using a Target-Mediated, Physiologic Recirculation Model and a Tracer Interaction Methodology”
    Drug Metabolism and Disposition July 2012, 40 (7) 1450; DOI: https://doi.org/10.1124/dmd.40.7.1450
  • You have access
    Correction to “Glucuronidation of Polychlorinated Biphenylols and UDP-Glucuronic Acid Concentrations in Channel Catfish Liver and Intestine”
    Drug Metabolism and Disposition July 2012, 40 (7) 1451; DOI: https://doi.org/10.1124/dmd.40.7.1451
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 40 (7)
Drug Metabolism and Disposition
Vol. 40, Issue 7
1 Jul 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Short Communications
  • Articles
  • Errata
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics